Materials and Methods

Reagents
Procedures
The assay was performed as follows: 0.4 ml of the mixed reagent was added to each of a series of glass tubes (10 X 75 mm or 12 X 75 mm). After addition of 0.1 ml of sample (or control) to each tube, the contents were mixed on a vortex-type mixer and incubated at ambient temperature for 1 h. After the appropriate incubation period, 0. 
Results
Analytical Variables
Response.
Our The data (Figure 2 ) indicated that the relative percentages of unbound '251-antigens were essentially unchanged at 4 and 25 #{176}C after storage for three months.
At 37 and 45 #{176}C, a decreased response was evident.
Over a six-month period, the percent deviation from the combined average at each of the concentrations of standard remained in the range of 1-5% for the reagent stored at 4 #{176}C. During the same interval, 
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Cross-reactivity.
Since we previously reported that cross-reactivity with codeine and high doses of dextromethorphan can occur in the individual assay for morphine (2) , the effect of these two drugs in the dual assay was investigated.
Urines from two volunteers, one receiving 20 mg of codeine and the other 60 mg of dextromethorphan, were tested in the dual assay (Table 2) . Urines from the individual taking codeine were positive in the dual assay at 2, 4, 8, and 26 h after drug administration.
Urines from the individual taking 60 mg dextromethorphan were negative by dual assay. 
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Additionally, fourteen commonly prescribed drugs were separately administered to subjects. Urine samples were collected from 0-4 h after single drug administration and tested with the dual assay. All urines were found to be negative at the 100 pg/liter equivalent level of either morphine or secobarbital (Table 3) . a Urine specimens collected at 0 and 4 h after dose administration. In each case, by the dual assay, the morphine/secobarbital equivalents were <100 Mg/liter. A sample was considered negative when the counts per minute were less than those of the 100 pg/liter morphine or secobarbital positive control.
Clinical Testing
pentobarbital, phenobarbital, and barbital. As indicated by the representative data for two individuals in Table 4, morphine was detected by the dual assay at 100 mg/liter sensitivity for specimens excreted up to 60 h after administration of a 10-mg intravenous dose. For subject 2, the 48-60 h urine sample contained 91 ng, sufficient to yield a positive result within the range of accuracy of the dual assay. All patients receiving the various barbiturates were detected by the dual assay at the 100 pg/liter level of sensitivity for at least 72 h after oral administration. 
